2022
DOI: 10.1016/j.hpb.2021.11.004
|View full text |Cite
|
Sign up to set email alerts
|

Enhancing the cost-effectiveness of surgical care in pancreatic cancer: a systematic review and cost meta-analysis with trial sequential analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 58 publications
0
4
0
Order By: Relevance
“…The use of ERAS-based clinical pathways for patients who had pancreatoduodenectomy due to pancreatic cancer has been shown to be effective for both increased patient care and reduced hospital costs according to the meta-analysis by Karunakaran et al [ 32 ]. The authors recorded a significant decrease in hospital stays, complications, and overall hospital costs through the ERAS arm of care compared with standard care [ 32 ].…”
Section: Eras and Surgical Oncologymentioning
confidence: 99%
See 1 more Smart Citation
“…The use of ERAS-based clinical pathways for patients who had pancreatoduodenectomy due to pancreatic cancer has been shown to be effective for both increased patient care and reduced hospital costs according to the meta-analysis by Karunakaran et al [ 32 ]. The authors recorded a significant decrease in hospital stays, complications, and overall hospital costs through the ERAS arm of care compared with standard care [ 32 ].…”
Section: Eras and Surgical Oncologymentioning
confidence: 99%
“…The use of ERAS-based clinical pathways for patients who had pancreatoduodenectomy due to pancreatic cancer has been shown to be effective for both increased patient care and reduced hospital costs according to the meta-analysis by Karunakaran et al [ 32 ]. The authors recorded a significant decrease in hospital stays, complications, and overall hospital costs through the ERAS arm of care compared with standard care [ 32 ]. The respective benefits have also been seen in patients with gastric cancer who underwent surgery with preoperative education, early rehabilitation with mobilization, and first postoperative day oral feeding [ 33 ].…”
Section: Eras and Surgical Oncologymentioning
confidence: 99%
“…Despite the availability of evidence that ERAS ® pathways for PD reduce post-operative length of stay [ 6 ], overall morbidity [ 7 ] and costs [ 8 ] without an increase in major complications, readmissions, reoperations, or mortality[ 6 ], its uptake has been slow in pancreatic surgery and has been dogged by low compliance even in centers that have adopted the pathways to enhance recovery [ 9 ]. While it may be surmised that availability of resources, or lack thereof, and the reluctance to change individual practice guided by dogmatism that focuses on the lack of sufficient evidence [ 10 ] of the benefits of ERAS ® , may be some of the reasons, the fact remains that global perceptions of ERAS ® in PD have not been systematically explored.…”
Section: Introductionmentioning
confidence: 99%
“…Perioperative nutrition is defined here as the implementation of nutrition interventions before and after the surgical procedure. Benefits for patients include not only reduction of postoperative complications and LOS, but also a sharp decrease in the cost of surgical procedures [6,7]. This review aims to provide an update of the recent evidence on the potential of perioperative nutritional interventions to benefit adult patients undergoing head and neck surgery of the digestive tract along with digestive surgical procedures.…”
Section: Introductionmentioning
confidence: 99%